LEADING EDGE BIO

Even top level executives often confuse strategy with trying to be the best at something. It is not a strategy to say we want to "be the best" at something. In order to create sustainable value over time, firms have to make tradeoffs that ultimately place them in unique positions that are difficult to replicate by competitors.

The industry's greatest challenges are no longer scientific. They are systemic.

Biotechnology has entered an era where scientific capability is expanding faster than any individual organization can fully exploit. That changes how companies should think about strategy. The future will not belong exclusively to the largest organizations or the smallest startups. It will belong to companies that consistently integrate discovery science, artificial intelligence, strategic partnerships, platform technologies, manufacturing, regulatory expertise, and commer